News

The report, titled ‘Targeting Emerging Delivery Technologies across the Value Chain: From Chemicals and Materials Suppliers to End-Products and Applications,’ applies the Lux Innovation Grid framework to evaluate

Glycofect is designed to be particularly effective in primary cells of therapeutic interest and is being used by government, university and corporate laboratories around the world for advanced

The designation follows the grant of orphan drug designation by the FDA for QLT091001 for the treatment of Leber Congenital Amaurosis (LCA). QLT091001 is an orally administered synthetic

Sopharma will break ground for its new plant on 9 December 2010 and will be investing $47m, according to novinite.com. The CEO of Sopharma Ognyan Donev, together with

AiCuris said that the trial has been completed two months earlier than planned. Indeed, in the later stages of the trial, enrollment had to be restricted as the

The new analysis ‘Strategic Analysis of Russian Pharmaceutical Market’ found that the market will reach $37.15bn in 2016. The Russian government initiative 2020 Pharmaceutical Development Programme (Pharma 2020)

The Pennsylvania facility has been engaged primarily in contract manufacturing of molded plastic components and assemblies for consumer-product applications. The Cornwall facility produces molded elastomeric components for disposable

Egrifta is a synthetic analogue of the human growth hormone releasing factor (GRF) shown to reduce visceral fat in HIV-infected patients with excess abdominal fat associated with lipodystrophy.

In the study, the patients receive chemotherapy concurrent with either Herceptin intravenous (IV) or Herceptin SC every three weeks for the first 8 cycles. Roche said that Herceptin